Notice: This company has been marked as potentially delisted and may not be actively trading. Urovant Sciences (UROV) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Xavier Creative House Appoints Jami Rogers as VP of Sales & MarketingNovember 4, 2024 | msn.comXavier Creative House Hires Jami Rogers as Vice President of Sales & MarketingOctober 29, 2024 | finance.yahoo.comPierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA(vibegron) in overactive bladder syndromeApril 26, 2024 | finanznachrichten.dePierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA™(vibegron) in overactive bladder syndromeApril 26, 2024 | finance.yahoo.comA2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of DirectorsMarch 26, 2024 | finance.yahoo.comPetauri™ Elects William Fleming and James Robinson to Its Board of DirectorsDecember 6, 2023 | finance.yahoo.comPM360 Announces 2023 Trailblazer Award WinnersOctober 4, 2023 | finance.yahoo.comEledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of DirectorsSeptember 11, 2023 | finance.yahoo.comCNVCF - BioHarvest Sciences Inc.July 31, 2023 | finance.yahoo.comUroGen Pharma Announces the Appointment of James Robinson to its Board of DirectorsJuly 25, 2023 | businesswire.comBenign Prostatic Hyperplasia Therapeutics Market Size Predictions suggest a rise of 5.1% CAGR, to reach value of USD 12.9 Billion by 2032July 20, 2023 | benzinga.comKPCW Cool Science RadioJune 24, 2023 | npr.orgOveractive Bladder Treatment Global Market Report 2023June 9, 2023 | uk.finance.yahoo.comPierre Fabre announces start of EU marketing authorization application procedure for Vibegron in overactive bladderMay 22, 2023 | finanznachrichten.deThree Japanese pharma subsidiaries to lay off 223 in MarlboroughMay 3, 2023 | bizjournals.comOveractive Bladder Market to Grow Rapidly at a Considerable CAGR During the Forecast Period (2023–2032) | DelveInsightMarch 28, 2023 | finance.yahoo.comDrugs for Enuresis Market 2023: Growth by 2029 Top Players with OpportunitiesFebruary 19, 2023 | marketwatch.comUrovant Sciences® Announces Collaboration with Holly Robinson Peete to Help Raise Awareness for Overactive Bladder and Treatment OptionsJanuary 19, 2023 | technews.tmcnet.comDrugs for Enuresis Market Share From 2023 To 2029 And Unlimited Opportunities for New Companies and Latest DevelopmentsJanuary 16, 2023 | marketwatch.comHow To Deal With An Overactive Bladder If You're Traveling Long Distance Over The HolidaysDecember 21, 2022 | msn.comRoivant Sciences: A Solid Year Of Progress And Good Prospects For 2023December 20, 2022 | seekingalpha.comUrovant Sciences Announces Publication of Pharmacokinetic Data on GEMTESA® (Vibegron 75mg) Administered as an Intact or Crushed TabletOctober 27, 2022 | finance.yahoo.comMyovant: Sumitomo Bid Is A Head Scratcher, Where Is The Value?October 4, 2022 | seekingalpha.com'I lose money every time I leave the house': Inflation complicates back-to-office pushSeptember 30, 2022 | financialpost.comSocial Science: What It Is and the 5 Major BranchesSeptember 26, 2022 | investopedia.comBest Global Universities for Computer ScienceSeptember 13, 2022 | usnews.comScience FridaySeptember 10, 2022 | npr.orgHealth and ScienceSeptember 8, 2022 | cnbc.comUrovant Sciences, Inc.: Urovant Sciences Named 17th on the List of Fortune Best Workplaces in BioPharma (2022)September 7, 2022 | finanznachrichten.deUrovant Sciences® Named 17th on the List of Fortune® Best Workplaces in BioPharma™ (2022)September 7, 2022 | finance.yahoo.comThe Impact of Urinary Incontinence Related to Overactive Bladder on Long-Term Care Residents and Facilities in the U.S. Highlighted in New SurveyJuly 13, 2022 | finance.yahoo.comUrovant Sciences, Inc.: Urovant Sciences Named One of 2022 "Best Places to Work" in Orange CountyJuly 9, 2022 | finanznachrichten.dePierre Fabre to commercialize Urovant's overactive bladder treatment vibegron in EuropeJuly 7, 2022 | seekingalpha.comOveractive Bladder Treatment (OAB) Market worth $4.2 Billion by 2027 - Exclusive Report by MarketsandMarketsJuly 5, 2022 | finanznachrichten.deUrovant Sciences, Inc.: Urovant Sciences Announces Appointment of Sef Kurstjens as Executive Vice President and Chief Medical OfficerApril 4, 2022 | finanznachrichten.deUrovant Sciences Announces Appointment of Sef Kurstjens as Executive Vice President and Chief Medical OfficerApril 4, 2022 | finance.yahoo.comCORRECTING and REPLACING Urovant Sciences Announces Appointment of Sef Kurstjens as Executive Vice President and Chief Medical OfficerApril 4, 2022 | apnews.comUrovant Sciences Announces Positive Topline Results of Phase 2a Trial of its Potential Novel Gene Therapy, URO-902March 7, 2022 | finance.yahoo.comMyovant Sciences Announces Financial Results for Second Quarter of Fiscal Year 2021 and Corporate UpdatesOctober 26, 2021 | stockhouse.comUrovant Sciences Announces Leadership Appointments to Drive Future Growth and Geographic ExpansionOctober 18, 2021 | finance.yahoo.comUrovant Sciences Appoints Betzy Estrada as Executive Vice President and Chief Human Resources OfficerAugust 12, 2021 | finance.yahoo.comUrovant Sciences Ltd. Common Shares (UROV)July 25, 2021 | nasdaq.com Get Urovant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for UROV and its competitors with MarketBeat's FREE daily newsletter. Email Address UROV Media Mentions By Week UROV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UROV News Sentiment▼0.000.47▲Average Medical News Sentiment UROV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UROV Articles This Week▼00▲UROV Articles Average Week Get Urovant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for UROV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SUPN News IDYA News NAMS News AGIO News WVE News SDGR News BLTE News GERN News DVAX News IRON News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UROV) was last updated on 2/6/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon Musk: The U.S. Dollar is Doomed Unless We ActBillionaire Warren Buffett told CNBC the U.S. dollar is on the path to disaster. And Charles Schwab reports, "...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored“The most important AI company Americans know least about…”If you own a smartphone, there’s a good chance you’re already benefiting from its technology—because it’s on h...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Urovant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Urovant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
